Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000054074
JPRN-UMIN000054074
Completed
未知

Research study on the treatment patterns of gastrointestinal stromal tumor (GIST) using the claims database - Research study on the treatment patterns of GIST

TAIHO PHARMACEUTICAL CO., LTD.0 sites1,847 target enrollmentApril 5, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
TAIHO PHARMACEUTICAL CO., LTD.
Enrollment
1847
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 5, 2024
End Date
November 24, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Patients with a record of antitumor drug prescription other than GIST drugs, at least 60 days before the first prescription of GIST drugs Patients who have a history of radical surgery for GIST, who have received Imatinib as the first prescription, and who have not received any GIST drugs after the completion of Imatinib treatment (adjuvant therapy period)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A fact-finding study on the treatment of gastroesophageal reflux disease (GERD) - Prospective study on therapeutic effects of proton pump inhibitors on reflux esophagitis
JPRN-UMIN000005271GERD Society120
Completed
Not Applicable
A fact-finding study on the treatment of gastroesophageal reflux disease (GERD) - Retrospective study on therapeutic effects of proton pump inhibitors on reflux esophagitisgastroesophageal reflux disease (GERD)
JPRN-UMIN000005272GERD Society500
Completed
Not Applicable
A fact-finding study on the treatment of gastroesophageal reflux disease (GERD) -Investigation of response to proton pump inhibitor (PPI) therapy and factors involved
JPRN-UMIN000006614GERD Society500
Active, not recruiting
Phase 1
The effects of Geotherapy on Heartburn and Reflux Symptoms: pilot clinical trial
RBR-44np8knisul
Active, not recruiting
Not Applicable
A Treatment Protocol for Patients with Gastrointestinal Stromal Tumor who are Ineligible for Participation in Other SU011248 Protocols AND are Refractory to or Intolerant of Imatinib Mesylate.Gastro-intestinal Stromal TumorsMedDRA version: 14.1Level: PTClassification code 10051066Term: Gastrointestinal stromal tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2004-001860-27-ITPFIZER1,098